These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11518732)

  • 1. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
    Dowd NP; Scully M; Adderley SR; Cunningham AJ; Fitzgerald DJ
    J Clin Invest; 2001 Aug; 108(4):585-90. PubMed ID: 11518732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
    Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
    Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
    Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F
    Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacology of naproxen sodium.
    Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
    J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
    Praticò D; Tillmann C; Zhang ZB; Li H; FitzGerald GA
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3358-63. PubMed ID: 11248083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine.
    Gross GJ; Moore J
    Pharmacology; 2004 Jul; 71(3):135-42. PubMed ID: 15161995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium salicylate inhibits prostaglandin formation without affecting the induction of cyclooxygenase-2 by bacterial lipopolysaccharide in vivo.
    Giuliano F; Mitchell JA; Warner TD
    J Pharmacol Exp Ther; 2001 Dec; 299(3):894-900. PubMed ID: 11714873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of cyclooxygenase (COX)-2 in experimental lung injury: evidence of a lipoxin A4-mediated effect.
    Scully M; Gang C; Condron C; Bouchier-Hayes D; Cunningham AJ
    J Surg Res; 2012 Jun; 175(1):176-84. PubMed ID: 21944479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts.
    Shinmura K; Nagai M; Tamaki K; Tani M; Bolli R
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2534-43. PubMed ID: 12388283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cyclooxygenase-2 in oleic acid-induced acute lung injury.
    Gust R; Kozlowski JK; Stephenson AH; Schuster DP
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1165-70. PubMed ID: 10508803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H; Izon DJ; Loftin C; Spain LM
    Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclo-oxygenase-2 induction in interleukin-1beta induced attenuation of cultured human airway smooth muscle cell cyclic AMP generation in response to isoprenaline.
    Pang L; Holland E; Knox AJ
    Br J Pharmacol; 1998 Nov; 125(6):1320-8. PubMed ID: 9863663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
    Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.
    Pidgeon GP; Tamosiuniene R; Chen G; Leonard I; Belton O; Bradford A; Fitzgerald DJ
    Circulation; 2004 Oct; 110(17):2701-7. PubMed ID: 15492320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.